Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD 0200390 Dose-Ranging Trial in Elderly Subjects with Primary Insomnia
NCT00748592Phase 2Withdrawn
- Sponsor
- Pfizer
- Start
- Jan 2009
- Primary completion
- Jun 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Atagabalin in Insomnia, sponsored by Pfizer. Planned start Jan 2009; status: withdrawn.
02
Drugs
Atagabalin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00748592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00748592.